Výsledky vyhledávání - "Tomoyuki, Kunishima"

Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry

Autor: Yutaka Hatori, Hiroyuki Sakai, Nobuo Hatori, Tomoyuki Kunishima, Atsuo Namiki, Makoto Shimizu, Nobuo Toyosaki, Masaomi Kuwajima, Naoki Sato

Publikováno v: Journal of Cardiology. 81:385-389

Oral anticoagulant therapy for atrial fibrillation (AF) has changed dramatically. Direct oral anticoagulant (DOAC) therapy is administered by general practitioners and specialists. However, the beneficial long-term effects and safety of DOACs have no

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f39e52c7b0500b1d894cd71bdd6297ba
https://doi.org/10.1016/j.jjcc.2022.08.012

Zobrazit plný text záznamu

Akademický článek

Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa)

Autor: Yutaka Hatori, MD, PhD, Hiroyuki Sakai, MD, PhD, Tomoyuki Kunishima, MD, PhD, Nobuo Hatori, MD, PhD, Lin Chen, MD, Tomoaki Ishigami, MD, PhD, Naoki Satoh, MD, PhD, FJCC

Publikováno v: Journal of Arrhythmia, Vol 33, Iss 2, Pp 111-116 (2017)

Background: Atrial fibrillation (AF) is one of the most prevalent cardiac arrhythmias associated with substantially increased risks of ischemic stroke and thromboembolism. Oral anticoagulants (OACs) are the cornerstone of AF management and effectivel

Externí odkaz: https://doaj.org/article/1b7e7c4aab0c4befba43440a72d830e6

Zobrazit plný text záznamu

Heterogeneity assessment of vaccine‐induced effects using point‐of‐care surrogate neutralization test for severe acute respiratory syndrome coronavirus 2

Autor: Yoshiyuki Watanabe, Ikuro Matsuba, Karin Watanabe, Tomoyuki Kunishima, Yukako Takechi, Tetsuo Takuma, Yasushi Araki, Nobuo Hirotsu, Hiroyuki Sakai, Ritsuko Oikawa, Hiroki Danno, Masakazu Fukuda, Seiji Futagami, Kota Wada, Hiroyuki Yamamoto, Fumio Itoh, Ichiro Oda, Yutaka Hatori, Hisakazu Degawa

Publikováno v: Journal of Clinical Laboratory Analysis. 36

Coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic even after vaccination. We aimed to identify immunological heterogeneity over time in vaccinated healthcare workers usi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c840c377ab97bce5950060df6e3f13a
https://doi.org/10.1002/jcla.24545

Zobrazit plný text záznamu

Akademický článek

Hydralazine inhibits ventricular tachyarrhythmias in an acquired long QT rabbit model

Autor: Kenta Tsutsui, MD, Satoshi Yamagishi, MD, Tomoyuki Kunishima, MD, Noriyuki Hayami, MD, Yuji Murakawa, MD

Publikováno v: Journal of Arrhythmia, Vol 30, Iss 3, Pp 157-160 (2014)

Background: Some cardioactive vasodilating agents inhibit ventricular tachyarrhythmias (VT) associated with acquired long QT syndrome (LQT). We tested whether a vasodilator without direct cardiac effect can eliminate abnormal repolarization-related V

Externí odkaz: https://doaj.org/article/dc2a0ed013f4493582ea6be923f90251

Zobrazit plný text záznamu

Survey of the current status of subclinical coronavirus disease 2019 (COVID-19)

Autor: Yoshiyuki Watanabe, Ikuro Matsuba, Masanori Nishikawa, Hisakazu Degawa, Yoko Matsuzawa, Tetsuo Nishikawa, Norihiko Koido, Futoshi Ebara, Yoshiaki Ono, Akira Kanamori, Nobuo Hatori, Tomoyuki Kunishima

Publikováno v: Journal of Infection and Chemotherapy

Objectives We investigated relationships between subclinical COVID-19 (coronavirus disease 2019) and background factors. Methods We determined SARS-CoV-2 antibody (IgG) prevalence in 1603 patients, doctors, and nurses in 65 medical institutions in Ka

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8b48ab53faf0cb156fb6f6060d1b973
https://doi.org/10.1016/j.jiac.2020.09.005

Zobrazit plný text záznamu

Study on Continuation of Antibody Prevalence Six Months after Detection of Subclinical Severe Acute Respiratory Syndrome Coronavirus 2 Infections

Autor: Akira Kanamori, Tomoyuki Kunishima, Nobuo Hatori, Hisakazu Degawa, Masahiko Takai, Tetsuo Nishikawa, Ikuro Matsuba, Nobukazu Takada, Yoko Matsuzawa, Yoshiyuki Watanabe, Yoshiaki Ono, Masanori Nishikawa, Tetsuo Takuma, Satoru Kishi

Publikováno v: Internal medicine (Tokyo, Japan). 61(2)

Objective To examine the continuation of antibody prevalence and background factors in antibody-positive subjects after asymptomatic infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Methods A study was carried out to inves

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c32122b6b868c80c087ea68900c856c
https://pubmed.ncbi.nlm.nih.gov/34744105

Zobrazit plný text záznamu

Rationale and design of ASSAF-K (A study of the safety and efficacy of anticoagulant therapy in the treatment of atrial fibrillation in Kanagawa)

Autor: Lin Chen, Yutaka Hatori, Hiroyuki Sakai, Naoki Satoh, Nobuo Hatori, Tomoyuki Kunishima, Tomoaki Ishigami

Publikováno v: Journal of Arrhythmia, Vol 33, Iss 2, Pp 111-116 (2017)
Journal of Arrhythmia

Background Atrial fibrillation (AF) is one of the most prevalent cardiac arrhythmias associated with substantially increased risks of ischemic stroke and thromboembolism. Oral anticoagulants (OACs) are the cornerstone of AF management and effectively

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e0ffff748bcf7987cd23cbb3564f53d
http://www.sciencedirect.com/science/article/pii/S1880427616300965

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání